She led the EDCTP2-funded BERC-Africa project, which strengthened regulatory capacity for clinical trials across multiple African countries by training staff from national regulatory authorities.
With over 30 years of experience, she rose through the ranks at the Food and Drugs Authority (FDA) Ghana to become its first female Chief Executive Officer in 2017. She was instrumental in achieving the designation of the FDA as a Regional Centre of Regulatory Excellence, and in developing and implementing Ghana’s Food Safety Policy and Food Emergency Response Plan.
In 2025, she was appointed the inaugural Director General of the African Medicines Agency (AMA). Her work has helped strengthen regulatory systems and ensure the safety and effectiveness of medicines across the continent. She was recognised on the TIME100 Health list in 2026 as a key health leader.
Discover more EDCTP-supported global health leaders
Professor Abdoulaye Djimdé is one of Africa’s leading experts on malaria genomics and antimalarial drug resistance.
Dr Christian Happi is a molecular biologist and genomic scientist internationally recognised for his work on infectious disease surveillance.
Dr Cissy Kityo is a physician and HIV researcher who played a pioneering role in introducing and scaling up antiretroviral therapy in Uganda.
Dr Delese Mimi Darko is a leading figure in medicines regulation in Africa.
Professor Marieke van der Zalm is a paediatric clinical researcher and one of the world’s leading experts on the long-term impact of tuberculosis (TB) on children’s lung health.
Dr Nicaise Ndembi is a renowned virologist and global health leader working at the intersection of science and policy.
Professor Pauline Byakika is a physician and infectious disease specialist whose research focuses on malaria treatment and the interactions between antimalarial and antiretroviral medicines.
Professor Salim Abdool Karim is one of Africa’s most prominent infectious disease epidemiologists.
Dr Stellah Mpagama is a leading tuberculosis (TB) researcher whose work focuses on improving TB treatment and understanding how other conditions, such as diabetes, affect TB outcomes.
Professor Tulio de Oliveira is a bioinformatician and global leader in genomic surveillance of infectious diseases.